Colorectal cancer: Is the new era of colorectal cancer classification finally here?

作者: Iris D. Nagtegaal , J. Han J. M. van Krieken

DOI: 10.1038/NRGASTRO.2013.90

关键词:

摘要: Colorectal cancer is a heterogeneous disease, with at least three well-known major, molecularly defined groups: the chromosomal instable, microsatellite instable and CpG island methylator phenotype. Although these groups differ in pathology, outcome response to therapy, this classification not used clinical management. Two recent studies might change perception.

参考文章(10)
Fred T Bosman, Fatima Carneiro, Ralph H Hruban, Neil D Theise, WHO Classification of Tumours of the Digestive System WHO classification of tumours of the digestive system.. ,(2010)
Timo Gaiser, Sandra Meinhardt, Daniela Hirsch, Jonathan Keith Killian, Jochen Gaedcke, Peter Jo, Immaculada Ponsa, Rosa Miró, Josef Rüschoff, Gerhard Seitz, Yue Hu, Jordi Camps, Thomas Ried, Molecular patterns in the evolution of serrated lesion of the colorectum. International Journal of Cancer. ,vol. 132, pp. 1800- 1810 ,(2013) , 10.1002/IJC.27869
Marleen J E M Gosens, Léon C L van Kempen, Cornelis J H van de Velde, J Han J M van Krieken, Iris D Nagtegaal, Loss of membranous Ep-CAM in budding colorectal carcinoma cells. Modern Pathology. ,vol. 20, pp. 221- 232 ,(2007) , 10.1038/MODPATHOL.3800733
Robert W. Werling, Hadi Yaziji, Carlos E. Bacchi, Allen M. Gown, CDX2, a highly sensitive and specific marker of adenocarcinomas of intestinal origin: an immunohistochemical survey of 476 primary and metastatic carcinomas. The American Journal of Surgical Pathology. ,vol. 27, pp. 303- 310 ,(2003) , 10.1097/00000478-200303000-00003
Johan H. J. M. van Krieken, Corine Jansen, Konnie M. Hebeda, Patricia J. T. A. Groenen, Biomarkers as disease definition: Mantle cell lymphoma as an example Proteomics Clinical Applications. ,vol. 4, pp. 922- 925 ,(2010) , 10.1002/PRCA.201000048
Felipe De Sousa E Melo, Xin Wang, Marnix Jansen, Evelyn Fessler, Anne Trinh, Laura PMH De Rooij, Joan H De Jong, Onno J De Boer, Ronald Van Leersum, Maarten F Bijlsma, Hans Rodermond, Maartje Van Der Heijden, Carel JM Van Noesel, Jurriaan B Tuynman, Evelien Dekker, Florian Markowetz, Jan Paul Medema, Louis Vermeulen, None, Poor-prognosis colon cancer is defined by a molecularly distinct subtype and develops from serrated precursor lesions Nature Medicine. ,vol. 19, pp. 614- 618 ,(2013) , 10.1038/NM.3174
Cecilia Guastadisegni, Mauro Colafranceschi, Laura Ottini, Eugenia Dogliotti, Microsatellite instability as a marker of prognosis and response to therapy: a meta-analysis of colorectal cancer survival data. European Journal of Cancer. ,vol. 46, pp. 2788- 2798 ,(2010) , 10.1016/J.EJCA.2010.05.009
Louise Hill, Gareth Browne, Eugene Tulchinsky, ZEB/miR-200 feedback loop: at the crossroads of signal transduction in cancer. International Journal of Cancer. ,vol. 132, pp. 745- 754 ,(2013) , 10.1002/IJC.27708
Anguraj Sadanandam, Costas A Lyssiotis, Krisztian Homicsko, Eric A Collisson, William J Gibb, Stephan Wullschleger, Liliane C Gonzalez Ostos, William A Lannon, Carsten Grotzinger, Maguy Del Rio, Benoit Lhermitte, Adam B Olshen, Bertram Wiedenmann, Lewis C Cantley, Joe W Gray, Douglas Hanahan, A colorectal cancer classification system that associates cellular phenotype and responses to therapy Nature Medicine. ,vol. 19, pp. 619- 625 ,(2013) , 10.1038/NM.3175
Al B. Benson, Deborah Schrag, Mark R. Somerfield, Alfred M. Cohen, Alvaro T. Figueredo, Patrick J. Flynn, Monika K. Krzyzanowska, Jean Maroun, Pamela McAllister, Eric Van Cutsem, Melissa Brouwers, Manya Charette, Daniel G. Haller, American Society of Clinical Oncology Recommendations on Adjuvant Chemotherapy for Stage II Colon Cancer Journal of Clinical Oncology. ,vol. 22, pp. 3408- 3419 ,(2004) , 10.1200/JCO.2004.05.063